Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glufosfamide +/- Hydration in Advanced Pancreatic Cancer
NCT00005053Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Dec 1999
- Primary completion
- Mar 2001
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of glufosfamide in pancreatic cancer (PC), sponsored by European Organisation for Research and Treatment of Cancer. Started Dec 1999; status: completed.
02
Drugs
glufosfamide
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00005053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005053.